Centene - CNC Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $85.23
Forecasted Upside: 9.57%
Number of Analysts: 12
Breakdown:
0 Sell Ratings
6 Hold Ratings
6 Buy Ratings
0 Strong Buy Ratings

^$77.79 As of 05/10/2024 01:00 AM ET

▲ +0.14 (0.18%)

1 month | 3 months | 12 months

Get New Centene Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

^$85.23

▲ +9.57% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $85.23, with a high forecast of $110.00 and a low forecast of $72.00. The average price target represents a 9.57% upside from the last price of $77.79.

Current Consensus is Moderate Buy

The current consensus among 12 contributing investment analysts is to moderate buy stock in Centene. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

11/17/2022

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

2/15/2023

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

5/16/2023

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

8/14/2023

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

11/12/2023

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

2/10/2024

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

4/10/2024

0 strong buy ratings
6 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

5/10/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/2/2024	Barclays	Boost Target	Overweight ➝ Overweight	$101.00 ➝ $104.00	Low
4/30/2024	Deutsche Bank Aktiengesellschaft	Boost Target	Hold ➝ Hold	$81.00 ➝ $82.00	Low
4/29/2024	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$110.00 ➝ $110.00	Low
4/15/2024	Wells Fargo & Company	Boost Target	Overweight ➝ Overweight	$89.00 ➝ $93.00	Low
4/8/2024	Wells Fargo & Company	Lower Target	Overweight ➝ Overweight	$94.00 ➝ $89.00	Low
4/4/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$90.00	Low
3/21/2024	Stephens	Reiterated Rating	Overweight ➝ Equal Weight	$92.00 ➝ $85.00	Low
3/20/2024	Wells Fargo & Company	Boost Target	Overweight ➝ Overweight	$90.00 ➝ $94.00	Low
3/6/2024	Barclays	Initiated Coverage	Overweight	$101.00	Low
1/2/2024	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$82.00 ➝ $90.00	Low
12/21/2023	Truist Financial	Boost Target	Buy ➝ Buy	$83.00 ➝ $86.00	Low
12/21/2023	UBS Group	Boost Target	Neutral ➝ Neutral	$72.00 ➝ $79.00	Low
12/15/2023	Cantor Fitzgerald	Boost Target	Overweight ➝ Overweight	$82.00 ➝ $90.00	Low
12/13/2023	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$74.00 ➝ $82.00	Low
11/21/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$82.00	Low
10/26/2023	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$71.00 ➝ $74.00	Low
10/9/2023	Jefferies Financial Group	Lower Target	Buy ➝ Buy	$82.00 ➝ $81.00	Low
9/14/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$82.00	Low
9/5/2023	Bank of America	Upgrade	Underperform ➝ Neutral	$79.00 ➝ $72.00	Low
8/30/2023	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$94.00 ➝ $73.00	Low
7/31/2023	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$110.00	Low
7/31/2023	Stephens	Lower Target		$87.00 ➝ $85.00	Low
7/31/2023	Barclays	Lower Target	Overweight	$86.00 ➝ $85.00	Low
7/14/2023	Morgan Stanley	Reiterated Rating	Overweight ➝ Overweight	$94.00	Low
7/12/2023	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		Low
7/11/2023	Mizuho	Lower Target		$80.00 ➝ $76.00	Low
7/7/2023	JPMorgan Chase & Co.	Lower Target		$81.00 ➝ $77.00	Low
6/20/2023	Truist Financial	Lower Target		$88.00 ➝ $83.00	Low
6/20/2023	UBS Group	Initiated Coverage	Neutral	$72.00	Low
4/26/2023	Stephens	Lower Target		$95.00 ➝ $87.00	Low
4/26/2023	Credit Suisse Group	Lower Target		$94.00 ➝ $87.00	Low
4/26/2023	Barclays	Lower Target		$90.00 ➝ $86.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$80.00	Low
4/11/2023	Barclays	Lower Target	Overweight	$93.00 ➝ $90.00	Low
3/21/2023	Wells Fargo & Company	Lower Target	Equal Weight	$79.00 ➝ $71.00	Low
3/9/2023	Morgan Stanley	Lower Target	Overweight	$103.00 ➝ $94.00	Low
3/8/2023	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$94.00 ➝ $79.00	Low
2/28/2023	Mizuho	Lower Target	Neutral	$92.00 ➝ $80.00	Low
2/23/2023	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$94.00 ➝ $90.00	Low
2/14/2023	Cowen	Lower Target	Outperform	$101.00 ➝ $97.00	Low
2/8/2023	The Goldman Sachs Group	Lower Target	Neutral	$97.00 ➝ $74.00	Low
2/8/2023	Mizuho	Reiterated Rating	Neutral	$92.00	Low
2/8/2023	JPMorgan Chase & Co.	Lower Target	Overweight	$98.00 ➝ $94.00	Low
2/8/2023	Loop Capital	Lower Target		$110.00 ➝ $95.00	Low
2/8/2023	Barclays	Lower Target	Overweight	$100.00 ➝ $93.00	Low
1/6/2023	JPMorgan Chase & Co.	Lower Target	Overweight	$103.00 ➝ $98.00	Low
12/19/2022	Credit Suisse Group	Boost Target	Outperform	$104.00 ➝ $106.00	Low
12/14/2022	Argus	Boost Target		$95.00 ➝ $99.00	Low
12/13/2022	Bank of America	Downgrade	Neutral ➝ Underperform	$100.00 ➝ $85.00	Low
10/26/2022	Deutsche Bank Aktiengesellschaft	Lower Target		$99.00 ➝ $94.00	Low
10/3/2022	Barclays	Lower Target	Overweight	$107.00 ➝ $100.00	Low
9/30/2022	Argus	Initiated Coverage	Buy	$90.00	Low
9/22/2022	Cowen	Lower Target		$108.00 ➝ $101.00	Low
9/22/2022	Cowen	Lower Target		$108.00 ➝ $101.00	Low
8/26/2022	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$103.00 ➝ $99.00	Low
8/9/2022	Cowen	Boost Target		$108.00	N/A
7/28/2022	Barclays	Initiated Coverage	Overweight ➝ Overweight	$107.00	Low
7/27/2022	Stephens	Boost Target	Outperform	$110.00	Low
7/27/2022	Oppenheimer	Boost Target	Outperform	$110.00	Low
7/27/2022	Truist Financial	Boost Target	Outperform	$102.00 ➝ $110.00	Low
7/27/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$91.00 ➝ $99.00	Low
7/19/2022	Credit Suisse Group	Set Target		$97.00	Low
7/14/2022	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$82.00 ➝ $115.00	Low
7/14/2022	Truist Financial	Boost Target	Buy	$100.00 ➝ $102.00	Low
6/23/2022	Morgan Stanley	Lower Target	Overweight	$112.00 ➝ $103.00	Low
6/22/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$88.00 ➝ $91.00	Low
6/21/2022	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$86.00 ➝ $88.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$100.00	Low
5/26/2022	Sanford C. Bernstein	Initiated Coverage	Outperform	$111.00 ➝ $108.00	High
5/26/2022	Bank of America	Downgrade	Buy ➝ Neutral	$95.00 ➝ $90.00	Medium
5/25/2022	Wells Fargo & Company	Lower Target	Overweight	$96.00 ➝ $95.00	Low
2/9/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$84.00 ➝ $88.00	Low
2/9/2022	Mizuho	Boost Target	Neutral	$78.00 ➝ $84.00	Medium
1/11/2022	Sanford C. Bernstein	Boost Target		$94.00 ➝ $108.00	High
1/7/2022	Barclays	Initiated Coverage	Overweight ➝ Overweight	$95.00	Medium
1/5/2022	Truist Financial	Boost Target	Buy ➝ Buy	$94.00 ➝ $96.00	High
12/17/2021	Morgan Stanley	Boost Target	Overweight	$86.00 ➝ $109.00	Low
12/14/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$83.00	High
12/13/2021	Truist Financial	Boost Target	Buy	$90.00 ➝ $94.00	Low
12/13/2021	Wolfe Research	Boost Target	Outperform	$72.00 ➝ $80.00	Low
12/13/2021	Stephens	Boost Target	Overweight ➝ Overweight	$82.00 ➝ $102.00	Low
12/13/2021	Bank of America	Boost Target	Buy	$85.00 ➝ $93.00	Low
12/13/2021	Oppenheimer	Boost Target	Outperform ➝ Outperform	$90.00 ➝ $95.00	Low
12/13/2021	Wells Fargo & Company	Boost Target	Overweight	$88.00 ➝ $90.00	Medium
12/13/2021	Credit Suisse Group	Boost Target	Neutral ➝ Neutral	$75.00 ➝ $86.00	Medium
12/13/2021	BMO Capital Markets	Boost Target	Outperform ➝ Outperform	$93.00 ➝ $100.00	Medium
12/13/2021	Mizuho	Boost Target	Neutral ➝ Neutral	$70.00 ➝ $78.00	Medium
11/1/2021	Citigroup	Downgrade	Buy ➝ Neutral	$77.00	Medium
10/27/2021	Credit Suisse Group	Boost Target	Neutral	$70.00 ➝ $75.00	High
10/27/2021	Morgan Stanley	Boost Target	Overweight	$79.00 ➝ $86.00	High
9/14/2021	Credit Suisse Group	Lower Target	Neutral	$73.50 ➝ $70.00	High
9/14/2021	Morgan Stanley	Lower Target	Overweight	$88.00 ➝ $79.00	High
9/9/2021	Cowen	Initiated Coverage	Outperform	$87.00	High
9/8/2021	Mizuho	Lower Target	Neutral	$75.00 ➝ $67.00	Medium
8/31/2021	Morgan Stanley	Lower Target	Overweight	$94.00 ➝ $88.00	Medium
8/17/2021	Roth Capital	Initiated Coverage	Buy		High
8/3/2021	Wells Fargo & Company	Lower Target	Overweight	$93.00 ➝ $88.00	Low
7/9/2021	Seaport Res Ptn	Reiterated Rating	Buy		Low
6/17/2021	Citigroup	Boost Target	Buy ➝ Buy	$80.00 ➝ $86.00	Medium
6/17/2021	Wells Fargo & Company	Boost Target	Overweight	$87.00 ➝ $93.00	High
6/17/2021	Oppenheimer	Reiterated Rating	Buy	$90.00	High
6/17/2021	BMO Capital Markets	Boost Target	Positive ➝ Outperform	$88.00 ➝ $93.00	High
6/17/2021	Mizuho	Boost Target	Neutral	$65.00 ➝ $75.00	High
6/8/2021	Bank of America	Boost Target	Buy	$75.00 ➝ $85.00	Low
5/24/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$87.00	N/A
5/18/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$87.00	Low
5/11/2021	BMO Capital Markets	Boost Target	Outperform	$77.00 ➝ $88.00	Medium
5/11/2021	Stephens	Upgrade	Equal Weight ➝ Overweight	$71.00 ➝ $87.00	Medium
4/28/2021	BMO Capital Markets	Lower Target		$88.00 ➝ $77.00	Medium
3/15/2021	Mizuho	Initiated Coverage	Neutral	$65.00	N/A
3/9/2021	Mizuho	Initiated Coverage	Neutral	$65.00	Low
1/21/2021	The Goldman Sachs Group	Initiated Coverage	Neutral		Low
1/15/2021	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$75.00 ➝ $72.00	Medium
12/21/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$83.00 ➝ $77.00	Medium
12/14/2020	SVB Leerink	Lower Target	Outperform	$80.00 ➝ $75.00	High
11/11/2020	Piper Sandler	Boost Target	Overweight	$83.00 ➝ $89.00	Medium
10/28/2020	Credit Suisse Group	Lower Target	Neutral	$72.50 ➝ $67.50	Medium
10/28/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$87.00 ➝ $83.00	High
10/28/2020	SVB Leerink	Boost Target	Outperform	$78.00 ➝ $80.00	High
9/22/2020	Stephens	Downgrade	Overweight ➝ Equal Weight		Medium
9/22/2020	Barclays	Boost Target	Overweight	$72.00 ➝ $84.00	High
7/29/2020	Jefferies Financial Group	Lower Target	Buy	$85.00 ➝ $83.00	Low
7/29/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$80.00 ➝ $87.00	Medium
7/1/2020	SVB Leerink	Initiated Coverage	Outperform	$78.00	High
6/12/2020	Oppenheimer	Initiated Coverage	Buy	$90.00	Low
4/29/2020	Bank of America	Reiterated Rating	Buy	$82.00	Low
4/29/2020	Credit Suisse Group	Reiterated Rating	Hold	$72.50	Low
4/29/2020	Citigroup	Boost Target	Buy	$70.00 ➝ $81.00	High
4/29/2020	Oppenheimer	Boost Target	Outperform	$83.00 ➝ $90.00	High
4/29/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$82.00 ➝ $80.00	High
4/28/2020	Oppenheimer	Reiterated Rating	Buy	$83.00	High
4/13/2020	Morgan Stanley	Boost Target	Overweight	$85.00 ➝ $89.00	Low
4/13/2020	SunTrust Banks	Boost Target	Buy	$85.00 ➝ $90.00	High
3/27/2020	Morgan Stanley	Boost Target	Overweight	$82.00 ➝ $85.00	Low
3/6/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$84.00 ➝ $82.00	Medium
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$68.00 ➝ $84.00	High
2/7/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$80.00	Low
2/5/2020	Citigroup	Boost Target	Buy	$65.00 ➝ $72.00	High
2/5/2020	JPMorgan Chase & Co.	Initiated Coverage	Neutral ➝ Overweight	$88.00	High
2/5/2020	Credit Suisse Group	Boost Target	Neutral	$65.00 ➝ $72.50	High
2/4/2020	Oppenheimer	Initiated Coverage	Buy	$83.00	High
2/3/2020	Evercore ISI	Initiated Coverage	Outperform	$90.00	Low
1/28/2020	Sanford C. Bernstein	Boost Target	Top Pick	$84.00 ➝ $103.00	High
1/24/2020	SunTrust Banks	Reiterated Rating	Buy	$77.00 ➝ $85.00	Low
1/24/2020	Wells Fargo & Company	Boost Target	Overweight	$72.00 ➝ $85.00	High
1/8/2020	Credit Suisse Group	Boost Target	Neutral	$57.00 ➝ $65.00	High
1/6/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$72.00	High
12/16/2019	Piper Sandler Companies	Reiterated Rating	Buy	$80.00	Medium
12/16/2019	BMO Capital Markets	Boost Target	Positive ➝ Outperform	$65.00 ➝ $70.00	High
10/23/2019	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$62.00 ➝ $60.00	Low
10/23/2019	Credit Suisse Group	Lower Target	Neutral	$63.00 ➝ $57.00	High
9/26/2019	Morgan Stanley	Lower Target	Overweight	$64.00 ➝ $62.00	High
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$62.00	High
8/23/2019	Morgan Stanley	Lower Target	Overweight	$71.00 ➝ $64.00	Medium
7/12/2019	Morgan Stanley	Lower Target	Overweight	$75.00 ➝ $71.00	Medium
5/10/2019	Citigroup	Upgrade	Neutral ➝ Buy	$69.00	Medium

(Data available from 5/10/2019 forward)

News Sentiment Rating

0.73 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

36 very positive mentions
11 positive mentions
11 negative mentions
3 very negative mentions

Mentions as of

10/13/2023

20 very positive mentions
25 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

11/12/2023

36 very positive mentions
10 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

12/12/2023

31 very positive mentions
23 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

1/11/2024

45 very positive mentions
41 positive mentions
6 negative mentions
1 very negative mentions

Mentions as of

2/10/2024

34 very positive mentions
35 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/11/2024

18 very positive mentions
37 positive mentions
5 negative mentions
2 very negative mentions

Mentions as of

4/10/2024

34 very positive mentions
37 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

5/10/2024

Current Sentiment

Recent Stories by Sentiment

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Today's Range

Now: $77.79

$77.60

$78.58

50 Day Range

MA: $75.48

$70.73

$79.66

52 Week Range

Now: $77.79

$60.83

$81.42

Volume

3,033,545 shs

Average Volume

3,178,902 shs

Market Capitalization

$41.51 billion

P/E Ratio

15.47

Dividend Yield

N/A

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?: The following equities research analysts have issued stock ratings on Centene in the last twelve months: Bank of America Co., Barclays PLC, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Stephens, StockNews.com, TheStreet, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for CNC.
What is the current price target for Centene?: 13 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $85.23, suggesting a possible upside of 9.6%. Oppenheimer Holdings Inc. has the highest price target set, predicting CNC will reach $110.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $72.00 for Centene in the next year.
View the latest price targets for CNC.
What is the current consensus analyst rating for Centene?: Centene currently has 6 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CNC.
What other companies compete with Centene?: Other companies that are similar to Centene include Humana, Molina Healthcare, The Cigna Group, Elevance Health and IDEXX Laboratories. Learn More about companies similar to Centene.
How do I contact Centene's investor relations team?: Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is (314) 725-4477 and its investor relations email address is [email protected]. The official website for Centene is www.centene.com. Learn More about contacing Centene investor relations.

Centene - CNC Stock Price Target and Predictions

Analyst Price Target for CNC

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.73 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

What is the current price target for Centene?

What is the current consensus analyst rating for Centene?

What other companies compete with Centene?

How do I contact Centene's investor relations team?